Micrococcus aerogenes (23) 14 or from chicken liver (24) ; crystalline samples of busulfan, 6-mercaptopurine, and chlorambucil; 15 nitrogen mustard; 16 and amethopterin, dichloramethopterin, and aminopterin. 17 Blood smears were stained with Wright's stain, and leukocyte counts were performed in duplicate. Hemoglobin was measured by its absorbancy at 410 my (millimolar extinction coefficient = 120). Protein was determined by the biuret method (25) with crystalline bovine serum albumin as the standard. Assay systems involving changes in absorbancy were performed in the Beckman spectrophotometer, model DU, with cuvettes of 1-cm optical path.
Ei-wyie assays
The various tetrahydrofolate-dependent enzymes (formate-activating enzyme (26) , N5,N10-methylene tetrahydrofolic dehydrogenase (27) , serine hydroxymethylase (28) , cyclohydrolase (29) , and N10-formyl tetrahydrofolate deacylase (29) were assayed in leukocyte lysates by the methods indicated in the above references. Detailed descriptions of these enzyme assays have been presented elsewhere (30, 31) . Serine hydroxymethylase was measured in most instances by coupling the hydroxymethylase reaction with N5,N10-methylene tetrahydrofolic dehydrogenase. This coupled assay for the hydroxymethylase, which requires that the dehydrogenase be present in excess, was valid for all leukocyte preparations except those of chronic lymphocytic leukemia. In the latter instance, serine hydroxymethylase was determined by an alternate method (32) based upon the tetrahydrofolate-and glycine-dependent disappearance of HCHO; Dihydrofolic reductase was measured by either the "direct" or "indirect" methods (14) . Assays for glucose-6-phosphate dehydrogenase (33) and lactic dehydrogenase (34) were performed by the indicated procedures.
The "levels" of the various enzymes are expressed in terms of their activities, i.e., micromoles of product formed per hour per milligram of protein in the lysate.
Assays were performed in duplicate at 370 C, and two or more different amounts (0.1 to 5.0 mg of protein) of lysate were used.
Clinical material "Normal" leukocytes were isolated from the blood of healthy donors at the King County Central Blood Bank. Patients with leukemia were studied before therapy or vere in relapse and not currently on any chemotherapeutic regimen. The leukocyte count of all patients with chronic lymphocytic leukemia exceeded 50,000 per ml with more than 85% small lymphocytes. Only those chronic myelocytic leukemia patients with leukocyte counts above 40,000 per ml and with more than 30% im-14 Kindly supplied by Dr. H. R. Whiteley. 15 Kindly supplied by Dr. S. Searle, Burroughs Wellcome and Co., Tuckahoe, N. Y. 16 Gift of Dr. D. M. Donohue. 17 Kindly supplied by J. M. Ruegsegger, Lederle Laboratories, Pearl River, N. Y. mature granulocytic forms were studied. In patients with acute leukemia, the leukocyte count exceeded 25,000 per ml, with at least 75% blast forms.
Isolation of leuikocytes
Human blood was collected in one of the following media: heparin, 2 mg per 100 ml of blood; acid-citratedextrose (National Institutes of Health, formula A), 15 ml per 100 ml of blood; or EDTA (0.75 g EDTA and 0.35 g NaCl in 50 ml of water), 10 ml per 100 ml of blood. The blood was processed within 30 minutes after collection, and all operations were performed at 40 C. Centrifugations were carried out in the International refrigerated centrifuge, model PR-2.
One vol of blood was added to 2 vol of 3% dextran in 0.15 M NaCl contained in a glass cylinder. The mixture was inverted carefully several times, and sedimentation under gravity was allowed to proceed for 30 minutes or until a distinct separation of the red cell layer had occurred. The supernatant fluid, containing most of the leukocytes, was removed and centrifuged for 4 minutes at 180 X 9. The supernatant fraction, containing most of the platelets, was discarded. Residual dextran was removed by mixing the leukocyte mass with 5 vol of 0.15 M NaCl, centrifuging for 4 minutes at 500 X g, and discarding the supernatant fluid.
Selective lysis of the remaining erythrocytes was performed by the addition of 3 vol of cold distilled water to the above leukocyte pellet. The cells were stirred vigorously for exactly 30 seconds, and the suspension was readjusted to isotonicity by the addition of 1 vol of 0.6 M KCl. After centrifugation for 4 minutes at 500 X g, the hemoglobin-containing supernatant fluid was discarded. Removal of the thin layer of red material (erythrocyte residues and platelets) above the leukocytes was accomplished by the careful addition of 1.0 ml of 0.15 M NaCl to the top of the pellet and gentle swirling of the fluid, with precautions to keep the bulk of the leukocyte pellet undisturbed. After removal of the supernatant fluid by aspiration, the remaining leukocytes were suspended in 10 vol of 0.15 M NaCl and centrifuged for 4 minutes at 500 X g. The supernatant fraction was discarded, and any red material still remaining at the top of the leukocyte pellet was removed again as described above. Finally, the leukocytes were suspended in 4 vol of 0.08 M potassium phosphate buffer, pH 7.5. 10 vol of reagent grade acetone previously cooled to -200 C. After 1 minute of vigorous stirring, the suspension was filtered through Whatman 1 filter paper on a precooled Buchner funnel, and the residue was washed with an additional 10 vol of acetone. The residue was dried in a gentle stream of air, and the resultant powder was stored at -20°C. Five vol of the desired buffer was added to the powder, and the mixture was stirred mechanically for 30 minutes; the soluble protein was recovered by high speed centrifugation, as described above.
Lyophilivation. One-ml portions of a 1: 4 suspension of leukocytes were lyophilized to dryness (approximately 2 hours). The powder was extracted with 5 vol of water, and the soluble protein was collected as described above.
Purification of forniatc-activating entiymec front normnal leukocytes Nine ml of lysate, containing 250 mg of protein, was adjusted to pH 7.4, and 2.8 ml of 2%o protamine sulfate was added. After the solution was stirred mechanically for 10 minutes, the precipitate was removed by centrifugation and discarded. Solid ammonium sulfate was added to the supernatant fluid until the concentration was increased to 35%o saturation (19.6 g per 100 ml), and the precipitate was discarded. The concentration of ammonium sulfate was then increased to 45%o saturation by the addition of 6.3 g per 100 ml, and the resulting precipitate was collected by centrifugation and dissolved in 2 ml of 0.05 M Tris buffer, pH 7.5. This procedure results in a five-to tenfold purification of the enzyme with a recovery of approximately 60%.
Purification of dihydrofolic reductase from letikentic leukocytes Two g of leukocyte acetone powder from a patient with leukemia was extracted for 1 hour with 20 ml of 0.05 M potassium phosphate buffer, pH 7.5. After centrifugation (10,900 X g for 15 minutes in the International refrigerated centrifuge, model PR-2), the supernatant fraction was collected and stirred mechanically for 15 minutes with 0.3 vol of 2%o protamine sulfate. The mixture was centrifuged, and the supernatant fluid (17.7 ml) was treated with 6.5 g of ammonium sulfate; after centrifugation the precipitate (0 to 55%o fraction) was discarded. To the supernatant fluid was added 5.4 g of ammonium sulfate to increase the concentration to 90%v.
The resulting precipitate (55 to 90%O fraction) was recovered by centrifugation, dissolved in 4.0 ml of 0.05 M phosphate buffer, pH 7.5, and dialyzed overnight against 0.002 M phosphate buffer, pH 7.5. Any precipitate that formed during dialysis was removed by centrifugation. The enzyme solution was treated with calcium phosphate gel as follows: 1 mg of gel (20 mg per ml) was added for each milligram of protein, and after adjusting the pH to 6.0 with 0.1 N acetic acid, the mixture was stirred for 10 minutes. After centrifugation, the gel was washed twice with 5-ml portions of water, and the enzyme was desorbed with the two 2-ml portions of 0.1 M phosphate buffer, pH 7.5. The enzyme preparation contained about 2.5 ml of protein per ml. At this stage, the enzyme has a specific activity (micromoles per hour per milligram protein) of approximately 0.3 to 0.4; this represents a purification of 15 to 20 times and a recovery of about 40%o based upon the acetone powder extract.
The above procedure was employed for the routine preparation of dihydrofolic reductase. Further purification could be accomplished by chromatography of the enzyme on DEAE cellulose. In the experiment illustrated in Figure 1 , a relatively large sample of reductase, purified by the above procedure (112 mg of protein, SA = 0.26), was made 10' M with respect to phosphate, pH 7.2, and then passed through a 2.2-X 15-cm column of DEAE cellulose. After adsorption of the protein, the column was eluted in a batchwise fashion with 10' M phosphate solutions containing various concentrations of KCl as indicated on the diagram. Ten-ml fractions were collected and analyzed for protein (by absorbancy at 280 mis) and for enzyme activity. Approximately onehalf of the total activity was recovered in tube 25, and the SA was 0.90 in this fraction.
RESULTS AND DISCUSSION
Preparation of leukocyte lysates. Leukocytes were isolated from whole blood in about 2 hours by a procedure that consisted of the removal of platelets by centrifugation, removal of most of the erythrocytes by sedimentation in the presence of dextran (35) , and selective lysis of the remaining erythrocytes in a hypotonic medium (36) . A similar method has been devised by Fallon and associates (37) . The yield of leukocytes was about 409o% from normal blood and as high as 60 to 90%o from leukemic blood. In normal blood there was some selective loss of lymphocytes during isolation so that the final suspension contained about 85% polymorphonuclear leukocytes.
The isolated leukocytes were essentially free from erythrocytes or platelets, and the cells were morphologically intact. XWhen heparin, ACD, and EDTA were compared as anticoagulants for the collection of blood, no differences were found in the yield of leukocytes or in the enzyme activities.
For To ascertain whether the method of lysis had any effect upon the recovery of enzyme activity, three representative enzymes were assayed after homogenization, freezing and thawing, and lyophilization of samples of the same cell suspension of normal leukocytes. From the data in Table II , it is evident that the levels of formate-activating enzyme, N5,N'0-methylene tetrahydrofolic dehydrogenase, and glucose-6-phosphate dehydrogenase are approximately the same, regardless of the lytic procedure employed.
Formate-activating enzyme. The formate-activating enzyme, which was detected earlier in normal leukocyte lysates (1), has been partially purified. Under optimal assay conditions, the extent of reaction was linear with time and with enzyme concentration, thus making it possible to define a unit of enzyme activity that may be used to compare the levels of this enzyme in lysates from various cell types.
The pH optimum of the leukocyte enzyme occurs at 7.4, and the reaction is carried out most Level of other enzymes involved in 1-carbon metabolism and carbohydrate metabolism. The levels of two other enzymes that utilize tetrahydrofolate as a coenzyme, namely, N5,N10-methylene tetrahydrofolic dehydrogenase and serine hydroxymethylase, are summarized in Table V . The amount of the former enzyme is essentially the same in normal cells and cells of the chronic letikemias, whereas the level in the acute leukemic cells of the adult or child is twice normal. Serine hydroxymethylase activity is about the same in normal and chronic myelocytic leukemic cells, about 1.5 to 2 times higher than normal in the acute leukemias, and 10 times higher in cells of chronic lymphocytic leukemia. The greatly elevated level of the enzyme in chronic lymphocytic leukemic cells may provide an explanation for Winzler's earlier observation (11) that the rate of incorporation of C14-formate into protein, presumably into the serine residues, is higher in these cells than in normal cells.
Cyclohydrolase has been detected in normal and chronic lymphocytic leukemic leukocytes at a level of approximately 0.3 umole per hour per mg of protein, but no detailed investigation was made of the comparative levels of this enzyme in various cell types. On the other hand, N10-formyl tetrahydrofolic deacylase is either nonexistent in nor- t Abbreviations as in Table I. I Data not available. mal and leukemic leukocytes or else the activity is too low to be detected by the present assay method.
For comparative purposes, a study was made of two representative enzymes of carbohydrate metabolism, namely, glucose-6-phosphate dehydrogenase and lactic dehydrogenase. The results are given also in Table V . As compared with normal cells, the level of glucose-6-phosphate dehydrogenase is decreased by about 50% in acute leukemia and chronic lymphocytic leukemia, and to a lesser extent in chronic myelocytic leukemia. Lactic dehydrogenase activity is elevated above normal in acute leukemia, but not in chronic lymphocytic leukemia. The lower levels of glucose-6-phosphate dehydrogenase in leukocytes from chronic myelocytic and chronic lymphocytic leukemia patients are in agreement with the observations of Beck (38) .
The above results characterize the leukocytes from chronic myelocytic leukemia and acute leukemia as cells containing higher levels of tetrahydrofolate-dependent enzyme systems when comparecl to normal leukocytes. This is consistent with the fact that these cells, even in the peripheral circulation, are capable of synthesizing DNA (39) , and tetrahydrofolate-dependent enzymes are involved, among other things, in the formation of the purine ring and the methyl group of the pyrimidine, thymine. Similarly, other enzymes involved in nucleic acid synthesis have been shown to be elevated in leukemic leukocytes when comlared to normal leukocytes, e.g., several enzymes in the pyrimidine biosynthesis pathway (40) , thymidylate synthetase (41) , and DNA polymerase (42) . The question might be raised as to whether such quantitative enzymatic differences observed between leukemic and normal leukocytes are inherent characteristics of the leukemic cell or whether they are also found in normal cells of comparable type and maturity. The finding of increased activity of tetrahydrofolate-dependent enzymes in lysates prepared from normal bone marrow aspirations 18 suggests that these alterations may not be specific for leukemia. This problem is difficult to resolve, however, until techniques become available for preparing immature normal cells of a uniform type (e.g., inyeloblasts) for comparative purposes.
Dihydrofolic reductase from leukemic leukocytes. Although the levels of the above tetrahydrofolate-dependent enzymes are about 2 times higher in acute leukemic cells as compared with normal cells, they are essentially insensitive to the folic acid antagonists. On the other hand, dihydrofolic reductase, the enzyme responsible for the conversion of folate and dihydrofolate to tetrahydrofolate, has been shown to be extremely sensitive to the antagonists, thereby providing an explanation for the effectiveness of these agents in the chemotherapy of leukemia. Additional interest in dihydrofolic reductase has been stimulated by the demonstration (43) that the enzyme also participates in the reductive methylation of deoxyuridylate to yield thymidylate (41 K+ or NH4+ has been observed, as in the case of dihydrofolic reductases from other tissues (45) . As reported previously, the Michaelis constants for TPNH and dihydrofolate with the leukocyte reductase are 3 x 10-6 M and 1 X 10-6 M, respectively (14) . It was found that dihydrofolic reductases, purified from cells of patients with either acute or chronic myelocytic leukemia, had the same pH optima, Michaelis constants, and requirement for cofactors. Most significantly, the leukocyte reductase is inhibited appreciably by the folic acid antagonists, aminopterin, amethopterin, and dichloroamethopterin at 10-8 M [Table II (14) ; Figure 1 (46) ].
Levels of dihydrofolic reductase in normal subjects and untreated leukemia patients. In lysates (17, 18) . We have reported previously (14) that dihydrofolic reductase could not be detected in normal and chronic lymphocytic leukemic leukocytes when these assays were performed with amounts of lysate protein up to 1.5 mg. When higher concentrations of lysate protein were used (5 to 10 mg per ml), however, a small, but significant, enzyme activity could be demonstrated in both the normal and chronic lymphocytic leukemic cells (Table VI) . Since these levels are at the lower limit of accuracy of the assay, dihydrofolic reductase was measured in a partially purified fraction from pooled samples of each cell type. 3) Formate-activating enzyme and dihydrofolic reductase have been partially purified from leukocytes. The following properties of these enzymes were determined: pH optimum, substrate and co-factor specificity, metal ion requirements, Michaelis constants, and sensitivity to inhibitors. Dihydrofolic reductase is inhibited by aminopterin and amethopterin at 10-8 M.
